Product Name | MF | CAS | Details |
---|
SARS-CoV-2 Nucleoprotein, 313-330 | Details |
SARS-CoV-2 Nucleoprotein, 360-375 | Details |
SARS-CoV-2 Nucleoprotein, 320-334 | Details |
SARS-CoV-2 Spike glycoprotein, 957-973 | Details |
SARS-CoV-2 Spike glycoprotein, 691-699 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 - Lys(Biotin - Ahx) | Details |
SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458 | Details |
Palmitoyl Tetrapeptide-7 | C34H62N8O7 | 221227-05-0 | Details |
Copper Tripeptide-3 | Details |
SARS-CoV-2 Nucleoprotein, 351-359 | Details |
SARS-CoV-2 Membrane protein, 89-97 | Details |
SARS-CoV-2 Spike glycoprotein, 1220-1228 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 - Lys(Biotin - Ahx) | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 | Details |
Palmitoyl Tripeptide-3 | 1447824-23-8 | Details |
Acetyl Tripeptide-30 Citrulline | 2098345-00-5 | Details |
Myristoyl Pentapeptide-4 | Details |
Hexapeptide-11 | 100684-36-4 | Details |
SARS-CoV-2 Nucleoprotein, 265-274 | Details |
SARS-CoV-2 Nucleoprotein, 329-346 | Details |
SARS-CoV-2 Spike glycoprotein, 424-433 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 - Lys(Biotin - Ahx) | Details |
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - Lys(Biotin - Ahx) | Details |
Tripeptide-3 | Details |
Acetyl Hydroxyproline | C7H11NO4 | 33996-33-7 | Details |
SARS-CoV-2 Nucleoprotein, 40-54 | Details |
SARS-CoV-2 Nucleoprotein, 325-339 | Details |
SARS-CoV-2 Spike glycoprotein, 958-966 | Details |
SARS-CoV-2 Spike glycoprotein, 747-763 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 | Details |
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 | Details |
Acetyl Dipeptide-1 Cetyl Ester | C33H57N5O5 | 196604-48-5 | Details |
Dipeptide-6 | C10H16N2O4 | 18684-24-7 | Details |
Palmitoyl Dipeptide-5 Diaminohydroxybutyrate | C35H63F6N5O9 | 794590-34-4 | Details |
Myristoyl Hexapeptide-4 | C41H79N9O11 | 959610-44-7 | Details |
SARS-CoV-2 Nucleoprotein, 305-322 | Details |
SARS-CoV-2 Nucleoprotein, 351-358 | Details |
SARS-CoV-2 Spike glycoprotein, 1011-1028 | Details |
SARS-CoV-2 Spike glycoprotein, 891-906 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 - Lys(Biotin - Ahx) | Details |
Acetyl Tetrapeptide-2 | C26H39N5O9 | 757942-88-4 | Details |
Acetyl Tetrapeptide-40 | C17H29N5O9 | 1472633-28-5 | Details |
Acetyl SH-Pentapeptide-1 | C32H51N9O10 | 97530-32-0 | Details |
Acetyl Dipeptide-3 Aminohexanoate | C17H32N6O5 | 1176133-78-0 | Details |
SARS-CoV-2 Nucleoprotein, 316-324 | Details |
SARS-CoV-2 Nucleoprotein, 329-353 | Details |
SARS-CoV-2 Spike glycoprotein, 1185-1193 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 - Lys(Biotin - Ahx) | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 | Details |
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 | Details |
Palmitoyl Pentapeptide-4 | C39H75N7O10 | 214047-00-4 | Details |
DX 600, ACE2 Inhibitor | Details |
Dipeptide-1 | C15H23N5O4 | 70904-56-2 | Details |
Trifluoroacetyl Tripeptide-2 | C21H28F3N3O6 | 64577-63-5 | Details |
Oligopeptide-6 | Details |
SH-Pentapeptide-1 | Details |
SARS-CoV-2 Nucleoprotein, 226-234 | Details |
SARS-CoV-2 Nucleoprotein, 125-139 | Details |
SARS-CoV-2 Spike glycoprotein, 976-984 | Details |
SARS-CoV-2 Spike glycoprotein, 647-664 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 - Lys(Biotin - Ahx) | Details |
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - Lys(Biotin - Ahx) | Details |
Acetyl Hexapeptide-49 | 1459205-54-9 | Details |
Oligopeptide-3 | Details |
Tetrapeptide-1 | C20H36N4O6 | 1632354-04-1 | Details |
SARS-CoV-2 Nucleoprotein, 305-319 | Details |
SARS-CoV-2 Nucleoprotein, 352-369 | Details |
SARS-CoV-2 Spike glycoprotein, 1060-1068 | Details |
SARS-CoV-2 Spike glycoprotein, 902-917 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 - Lys(Biotin - Ahx) | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 | Details |
Angiotensin I Converting Enzyme 2, (ACE - 2) Substrate | C32H36N6O12 | 305336-82-7 | Details |
Tripeptide-10 Citrulline | C22H42N8O7 | 960531-53-7 | Details |
SARS-CoV-2 Nucleoprotein, 322-331 | Details |
SARS-CoV-2 Membrane protein, 61-70 | Details |
SARS-CoV-2 Spike glycoprotein, 1192-1200 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 - Lys(Biotin - Ahx) | Details |
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - Lys(Biotin - Ahx) | Details |
Hexapeptide-9 | 1228371-11-6 | Details |
Palmitoyl Dipeptide-5 Diaminobutyroyl Hydroxythreonine | C39H70F6N6O11 | 883558-32-5 | Details |
Acetyl Tetrapeptide-15 | C34H39N5O6 | 928007-64-1 | Details |
Acetyl Hexapeptide-38 | 1400634-44-7 | Details |
Decapeptide-12 | C65H90N18O17 | 137665-91-9 | Details |
Palmitoyl Tripeptide-8 | C37H61N9O4 | 936544-53-5 | Details |
ARGININE/LYSINE POLYPEPTIDE | 74-79-3/56-87-1 | Details |
SARS-CoV-2 Nucleoprotein, 260-274 | Details |
SARS-CoV-2 Nucleoprotein, 215-229 | Details |
SARS-CoV-2 Spike glycoprotein, 996-1004 | Details |
(Biotin - Ahx) - SARS - CoV - 2 Spike RBM (receptor binding motif) | Details |
SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 | Details |
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 | Details |
Acetyl Tetrapeptide-11 | C27H38N4O7 | 928006-88-6 | Details |
Acetyl Tetrapeptide-9 | C22H33N7O9 | 928006-50-2 | Details |
Oligopeptide-10 | C78H140N20O15 | 466691-40-7 | Details |
Hexapeptide-10 | C28H53N7O8 | 146439-94-3 | Details |
Hexapepitde-3 | Details |
Tetrapeptide-4 | Details |
Product Total: Product Page: | ||||
40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |